Article info

Original research
Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases

Authors

  • Marie Kroemer INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, University of Bourgogne Franche-Comté, F-25000 Besançon, France Department of Pharmacy, University hospital of Besançon, F-25000 Besançon, France PubMed articlesGoogle scholar articles
  • Celia Turco INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, University of Bourgogne Franche-Comté, F-25000 Besançon, France Department of Digestive and Oncologic Surgery, Liver Transplantation Unit, University hospital of Besançon, F-25000 Besançon, France PubMed articlesGoogle scholar articles
  • Laurie Spehner INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, University of Bourgogne Franche-Comté, F-25000 Besançon, France PubMed articlesGoogle scholar articles
  • Julien Viot INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, University of Bourgogne Franche-Comté, F-25000 Besançon, France Department of Medical Oncology, University hospital of Besançon, F-25000 Besançon, France PubMed articlesGoogle scholar articles
  • Idir Idirène INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, University of Bourgogne Franche-Comté, F-25000 Besançon, France PubMed articlesGoogle scholar articles
  • Adeline Bouard INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, University of Bourgogne Franche-Comté, F-25000 Besançon, France ITAC platform, University of Bourgogne Franche-Comté, F-25000 Besançon, France PubMed articlesGoogle scholar articles
  • Elodie Renaude INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, University of Bourgogne Franche-Comté, F-25000 Besançon, France PubMed articlesGoogle scholar articles
  • Marina Deschamps INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, University of Bourgogne Franche-Comté, F-25000 Besançon, France PubMed articlesGoogle scholar articles
  • Yann Godet INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, University of Bourgogne Franche-Comté, F-25000 Besançon, France PubMed articlesGoogle scholar articles
  • Olivier Adotévi INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, University of Bourgogne Franche-Comté, F-25000 Besançon, France Department of Medical Oncology, University hospital of Besançon, F-25000 Besançon, France PubMed articlesGoogle scholar articles
  • Samuel Limat INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, University of Bourgogne Franche-Comté, F-25000 Besançon, France Department of Pharmacy, University hospital of Besançon, F-25000 Besançon, France PubMed articlesGoogle scholar articles
  • Bruno Heyd INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, University of Bourgogne Franche-Comté, F-25000 Besançon, France Department of Digestive and Oncologic Surgery, Liver Transplantation Unit, University hospital of Besançon, F-25000 Besançon, France PubMed articlesGoogle scholar articles
  • Marine Jary INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, University of Bourgogne Franche-Comté, F-25000 Besançon, France Department of Medical Oncology, University hospital of Besançon, F-25000 Besançon, France PubMed articlesGoogle scholar articles
  • Romain Loyon INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, University of Bourgogne Franche-Comté, F-25000 Besançon, France PubMed articlesGoogle scholar articles
  • Christophe Borg INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, University of Bourgogne Franche-Comté, F-25000 Besançon, France Department of Medical Oncology, University hospital of Besançon, F-25000 Besançon, France ITAC platform, University of Bourgogne Franche-Comté, F-25000 Besançon, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Marie Kroemer; mkroemer{at}chu-besancon.fr
View Full Text

Citation

Kroemer M, Turco C, Spehner L, et al
Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases

Publication history

  • Accepted October 16, 2020
  • First published November 23, 2020.
Online issue publication 
November 23, 2020
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.